{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:05:17Z","timestamp":1779897917040,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bvth.2026.100144","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:15:13Z","timestamp":1770333313000},"page":"100144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patients"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8350-3989","authenticated-orcid":false,"given":"Diana","family":"Mu\u00f1oz Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2001-1205","authenticated-orcid":false,"given":"Eva R.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-7224","authenticated-orcid":false,"given":"Felipe","family":"Rojas-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2093-3604","authenticated-orcid":false,"given":"Pieter F.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4585-2621","authenticated-orcid":false,"given":"Jan","family":"Voorberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"van der Zwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4718-1764","authenticated-orcid":false,"given":"Pieter","family":"Langerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-2289","authenticated-orcid":false,"given":"Arie J.","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8122-190X","authenticated-orcid":false,"given":"Teunis J. P.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5107-047X","authenticated-orcid":false,"given":"Jean-Louis","family":"Kerkhoffs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-7979","authenticated-orcid":false,"given":"Paula F.","family":"Ypma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-5496","authenticated-orcid":false,"given":"Maartje","family":"van den Biggelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.bvth.2026.100144_bib1","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"9850","key":"10.1016\/j.bvth.2026.100144_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bvth.2026.100144_bib3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjh.14631","article-title":"Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia","volume":"177","author":"Ho","year":"2017","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.bvth.2026.100144_bib4","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10 \u00d7 109\/L trigger for prophylactic platelet transfusions compared with the traditional 20 \u00d7 109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bvth.2026.100144_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.bvth.2026.100144_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bvth.2026.100144_bib7","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation","volume":"2015","author":"Crighton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.bvth.2026.100144_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2017-01-757930","article-title":"Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial","volume":"130","author":"Uhl","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfus Med Rev"},{"issue":"9","key":"10.1016\/j.bvth.2026.100144_bib10","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1111\/trf.16587","article-title":"Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks","volume":"61","author":"Cornelissen","year":"2021","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.16291","article-title":"The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study","volume":"189","author":"Ypma","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41231-024-00189-5","article-title":"Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation","volume":"9","author":"Smit","year":"2024","journal-title":"Transl Med Commun"},{"issue":"2","key":"10.1016\/j.bvth.2026.100144_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2018-02-831289","article-title":"Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial","volume":"132","author":"Van Der Meer","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010156","article-title":"A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial","volume":"6","author":"Ypma","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.bvth.2026.100144_bib15","author":"Kassambara","year":"2023","journal-title":"rstatix: Pipe-Friendly Framework for Basic Statistical Tests"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.bvth.2026.100144_bib17","series-title":"Modern Applied Statistics with S","author":"Venables","year":"2002"},{"key":"10.1016\/j.bvth.2026.100144_bib18","author":"Harrell","year":"2023","journal-title":"Hmisc: Harrell Miscellaneous"},{"issue":"11","key":"10.1016\/j.bvth.2026.100144_bib19","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"7","key":"10.1016\/j.bvth.2026.100144_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bvth.2026.100144_bib21","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"issue":"D1","key":"10.1016\/j.bvth.2026.100144_bib22","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.bvth.2026.100144_bib23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/trf.18397","article-title":"Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato-oncological patients","volume":"65","author":"Smit","year":"2025","journal-title":"Transfusion (Paris)"},{"issue":"5","key":"10.1016\/j.bvth.2026.100144_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bmt.1703381","article-title":"Acquired factor VII deficiency in hematopoietic stem cell transplant recipients","volume":"29","author":"Toor","year":"2002","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.bvth.2026.100144_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MBC.0000000000000024","article-title":"Acquired factor VII deficiency associated with acute myeloid leukemia","volume":"26","author":"Anoun","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.bvth.2026.100144_bib26","article-title":"Acquired factor VII deficiency associated with chronic myeloid leukemia blast crisis","volume":"11","author":"Wolf","year":"2023","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"3","key":"10.1016\/j.bvth.2026.100144_bib27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1538-7836.2003.t01-5-00177.x","article-title":"Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia","volume":"1","author":"Hoffman","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bvth.2026.100144_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.10056","article-title":"Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage","volume":"69","author":"Gerotziafas","year":"2002","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100144_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703157","article-title":"Off-label use of recombinant factor VIIa in patients following bone marrow transplantation","volume":"28","author":"Blatt","year":"2001","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.bvth.2026.100144_bib30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI86154","article-title":"Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia","volume":"127","author":"Pleines","year":"2017","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.bvth.2026.100144_bib31","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood-2008-06-164061","article-title":"Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation","volume":"113","author":"Eckly","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41420-022-01263-3","article-title":"Proteomic and functional profiling of platelet-derived extracellular vesicles released under physiological or tumor-associated conditions","volume":"8","author":"Vismara","year":"2022","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.bvth.2026.100144_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1537-2995.2002.00040.x","article-title":"Reticulated platelets predict platelet count recovery following chemotherapy","volume":"42","author":"Wang","year":"2002","journal-title":"Transfusion (Paris)"},{"issue":"11","key":"10.1016\/j.bvth.2026.100144_bib34","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1007\/s00277-024-05951-1","article-title":"Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation","volume":"103","author":"Yang","year":"2024","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100144_bib35","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/jth.14895","article-title":"Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets","volume":"18","author":"Hille","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bvth.2026.100144_bib36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1055\/s-0039-1695009","article-title":"Transcriptome analysis of reticulated platelets reveals a prothrombotic profile","volume":"119","author":"Bongiovanni","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bvth.2026.100144_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.lungcan.2018.09.011","article-title":"Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform","volume":"125","author":"Dejima","year":"2018","journal-title":"Lung Cancer"},{"issue":"22","key":"10.1016\/j.bvth.2026.100144_bib38","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1182\/blood-2013-06-506691","article-title":"Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the \u03b1IIb\u03b23 integrin","volume":"122","author":"Wang","year":"2013","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bvth.2026.100144_bib39","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1084\/jem.20071800","article-title":"Talin is required for integrin-mediated platelet function in hemostasis and thrombosis","volume":"204","author":"Petrich","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100144_bib40","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1038\/s41598-018-29151-w","article-title":"The membrane-associated fraction of cyclase associate protein 1 translocates to the cytosol upon platelet stimulation","volume":"8","author":"Joshi","year":"2018","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.bvth.2026.100144_bib41","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1091\/mbc.e10-05-0459","article-title":"The roles of two distinct regions of PINCH-1 in the regulation of cell attachment and spreading","volume":"21","author":"Ito","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bvth.2026.100144_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100685","article-title":"Molecular basis for Ras suppressor-1 binding to PINCH-1 in focal adhesion assembly","volume":"296","author":"Fukuda","year":"2021","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.bvth.2026.100144_bib43","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.2017.185165","article-title":"Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy","volume":"103","author":"Baaten","year":"2018","journal-title":"Haematologica"}],"container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:21:12Z","timestamp":1779895272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2950327226000094"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100144","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patients","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100144"}}